These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9365493)

  • 41. [Demography and effects of chronic renal insufficiency in Ile-de-France].
    Jungers P; Giraud E; Chauveau P; Geffriaud-Ricouard C; Man NK; Altman JJ; Jacobs C; Grünfeld JP
    Nephrologie; 1996; 17(8):429-34. PubMed ID: 9036365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does early anemia correction prevent complications of chronic renal failure?
    Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
    Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ten-year experience in renal replacement therapy in children. A report from Dialysis Center, Department of Pediatric Nephrology, Children's University Hospital in Lublin].
    Zajaczkowska M; Kołłataj B; Bieniaś B; Wieczorkiewicz-Płaza A; Borzecka H; Sikora P; Majewski M
    Przegl Lek; 2006; 63 Suppl 3():162-5. PubMed ID: 16898520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late diagnosis of chronic renal failure.
    Sesso R; Belasco AG; Ajzen H
    Braz J Med Biol Res; 1996 Nov; 29(11):1473-8. PubMed ID: 9196548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of impeding factors for dry weight achievement in end-stage renal disease after appropriate kidney graft function.
    Rivera-González SC; Pérez-Grovas H; Madero M; Mora-Bravo F; Saavedra N; López-Rodriguez J; Lerma C
    Artif Organs; 2014 Feb; 38(2):113-20. PubMed ID: 23889479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Biological adequacy--what does it mean?].
    Kes P; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2004; 58(1):1-4. PubMed ID: 15125386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late referral defined by renal function: association with morbidity and mortality.
    Lhotta K; Zoebl M; Mayer G; Kronenberg F
    J Nephrol; 2003; 16(6):855-61. PubMed ID: 14736013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Benefits of early nephrological management in chronic renal failure].
    Jungers P; Skhiri H; Zingraff J; Muller S; Fumeron C; Giatras I; Touam M; Nguyen AT; Man NK; Grünfeld JP
    Presse Med; 1997 Sep; 26(28):1325-9. PubMed ID: 9365486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
    Foote C; Clayton PA; Johnson DW; Jardine M; Snelling P; Cass A
    Am J Kidney Dis; 2014 Sep; 64(3):359-66. PubMed ID: 24787762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [How do we optimize the management of chronic renal failure?].
    Laville M; Duru G
    Therapie; 2001; 56(5):533-43. PubMed ID: 11806290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Complications of treatment by dialysis].
    Leteif M; Viron B; Michel C; Mignon F
    Presse Med; 1997 Mar; 26(9):407-9. PubMed ID: 9137392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progressive renal failure.
    el Nahas AM; Coles GA
    J R Coll Physicians Lond; 1997; 31(1):27-31. PubMed ID: 9044194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic renal insufficiency: a diagnostic and therapeutic approach.
    Rahman M; Smith MC
    Arch Intern Med; 1998 Sep; 158(16):1743-52. PubMed ID: 9738603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Supply of care and prevention].
    Landais P
    Presse Med; 2002 Feb; 31(4):176-85. PubMed ID: 11865727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preventing chronic kidney disease in France: advantages, feasibility and concerns].
    Duranton F; Brunet P; Laville M; Landais P; Daurès JP; Mourad G; Bustins M; Argilés A
    Nephrol Ther; 2014 Dec; 10(7):492-9. PubMed ID: 25457993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preservation of renal function in chronic renal failure.
    Whitworth JA; Ihle BU; Becker GJ; Kincaid-Smith PS
    Tohoku J Exp Med; 1992 Jan; 166(1):165-83. PubMed ID: 1412442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease.
    Gupta D; Gardner M; Whaley-Connell A
    Cardiorenal Med; 2011; 1(3):174-182. PubMed ID: 22258540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal diseases and transplantation in children.
    El-Mekresh MM
    Curr Opin Urol; 1998 Nov; 8(6):517-23. PubMed ID: 17039069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.